The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hemostatic Agents Market Research Report 2024
Synopsis
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
The global Hemostatic Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The world's leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LiLifeSciences, B Braun Melsungen and Gelita Medical.
This report aims to provide a comprehensive presentation of the global market for Hemostatic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Agents.
Report Scope
The Hemostatic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostatic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Nursing Homes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
The global Hemostatic Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The world's leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LiLifeSciences, B Braun Melsungen and Gelita Medical.
This report aims to provide a comprehensive presentation of the global market for Hemostatic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Agents.
Report Scope
The Hemostatic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostatic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Nursing Homes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hemostatic Agents Market Overview
1.1 Product Overview and Scope of Hemostatic Agents
1.2 Hemostatic Agents Segment by Type
1.2.1 Global Hemostatic Agents Market Value Comparison by Type (2024-2030)
1.2.2 Gelation Sponge
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Others
1.3 Hemostatic Agents Segment by Application
1.3.1 Global Hemostatic Agents Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Nursing Homes
1.4 Global Hemostatic Agents Market Size Estimates and Forecasts
1.4.1 Global Hemostatic Agents Revenue 2019-2030
1.4.2 Global Hemostatic Agents Sales 2019-2030
1.4.3 Global Hemostatic Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hemostatic Agents Market Competition by Manufacturers
2.1 Global Hemostatic Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hemostatic Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hemostatic Agents Average Price by Manufacturers (2019-2024)
2.4 Global Hemostatic Agents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostatic Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostatic Agents, Product Type & Application
2.7 Hemostatic Agents Market Competitive Situation and Trends
2.7.1 Hemostatic Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hemostatic Agents Players Market Share by Revenue
2.7.3 Global Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hemostatic Agents Retrospective Market Scenario by Region
3.1 Global Hemostatic Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hemostatic Agents Global Hemostatic Agents Sales by Region: 2019-2030
3.2.1 Global Hemostatic Agents Sales by Region: 2019-2024
3.2.2 Global Hemostatic Agents Sales by Region: 2025-2030
3.3 Global Hemostatic Agents Global Hemostatic Agents Revenue by Region: 2019-2030
3.3.1 Global Hemostatic Agents Revenue by Region: 2019-2024
3.3.2 Global Hemostatic Agents Revenue by Region: 2025-2030
3.4 North America Hemostatic Agents Market Facts & Figures by Country
3.4.1 North America Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hemostatic Agents Sales by Country (2019-2030)
3.4.3 North America Hemostatic Agents Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostatic Agents Market Facts & Figures by Country
3.5.1 Europe Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hemostatic Agents Sales by Country (2019-2030)
3.5.3 Europe Hemostatic Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostatic Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hemostatic Agents Sales by Country (2019-2030)
3.6.3 Asia Pacific Hemostatic Agents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hemostatic Agents Market Facts & Figures by Country
3.7.1 Latin America Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hemostatic Agents Sales by Country (2019-2030)
3.7.3 Latin America Hemostatic Agents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostatic Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hemostatic Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hemostatic Agents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hemostatic Agents Sales by Type (2019-2030)
4.1.1 Global Hemostatic Agents Sales by Type (2019-2024)
4.1.2 Global Hemostatic Agents Sales by Type (2025-2030)
4.1.3 Global Hemostatic Agents Sales Market Share by Type (2019-2030)
4.2 Global Hemostatic Agents Revenue by Type (2019-2030)
4.2.1 Global Hemostatic Agents Revenue by Type (2019-2024)
4.2.2 Global Hemostatic Agents Revenue by Type (2025-2030)
4.2.3 Global Hemostatic Agents Revenue Market Share by Type (2019-2030)
4.3 Global Hemostatic Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hemostatic Agents Sales by Application (2019-2030)
5.1.1 Global Hemostatic Agents Sales by Application (2019-2024)
5.1.2 Global Hemostatic Agents Sales by Application (2025-2030)
5.1.3 Global Hemostatic Agents Sales Market Share by Application (2019-2030)
5.2 Global Hemostatic Agents Revenue by Application (2019-2030)
5.2.1 Global Hemostatic Agents Revenue by Application (2019-2024)
5.2.2 Global Hemostatic Agents Revenue by Application (2025-2030)
5.2.3 Global Hemostatic Agents Revenue Market Share by Application (2019-2030)
5.3 Global Hemostatic Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ethicon
6.1.1 Ethicon Corporation Information
6.1.2 Ethicon Description and Business Overview
6.1.3 Ethicon Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ethicon Hemostatic Agents Product Portfolio
6.1.5 Ethicon Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Hemostatic Agents Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Baxter International
6.3.1 Baxter International Corporation Information
6.3.2 Baxter International Description and Business Overview
6.3.3 Baxter International Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Baxter International Hemostatic Agents Product Portfolio
6.3.5 Baxter International Recent Developments/Updates
6.4 C. R. Bard
6.4.1 C. R. Bard Corporation Information
6.4.2 C. R. Bard Description and Business Overview
6.4.3 C. R. Bard Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 C. R. Bard Hemostatic Agents Product Portfolio
6.4.5 C. R. Bard Recent Developments/Updates
6.5 The Medicines Company
6.5.1 The Medicines Company Corporation Information
6.5.2 The Medicines Company Description and Business Overview
6.5.3 The Medicines Company Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 The Medicines Company Hemostatic Agents Product Portfolio
6.5.5 The Medicines Company Recent Developments/Updates
6.6 Anika Therapeutics
6.6.1 Anika Therapeutics Corporation Information
6.6.2 Anika Therapeutics Description and Business Overview
6.6.3 Anika Therapeutics Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Anika Therapeutics Hemostatic Agents Product Portfolio
6.6.5 Anika Therapeutics Recent Developments/Updates
6.7 Advanced Medical Solutions
6.6.1 Advanced Medical Solutions Corporation Information
6.6.2 Advanced Medical Solutions Description and Business Overview
6.6.3 Advanced Medical Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Advanced Medical Solutions Hemostatic Agents Product Portfolio
6.7.5 Advanced Medical Solutions Recent Developments/Updates
6.8 Integra LifeSciences
6.8.1 Integra LifeSciences Corporation Information
6.8.2 Integra LifeSciences Description and Business Overview
6.8.3 Integra LifeSciences Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Integra LifeSciences Hemostatic Agents Product Portfolio
6.8.5 Integra LifeSciences Recent Developments/Updates
6.9 B Braun Melsungen
6.9.1 B Braun Melsungen Corporation Information
6.9.2 B Braun Melsungen Description and Business Overview
6.9.3 B Braun Melsungen Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 B Braun Melsungen Hemostatic Agents Product Portfolio
6.9.5 B Braun Melsungen Recent Developments/Updates
6.10 Gelita Medical
6.10.1 Gelita Medical Corporation Information
6.10.2 Gelita Medical Description and Business Overview
6.10.3 Gelita Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Gelita Medical Hemostatic Agents Product Portfolio
6.10.5 Gelita Medical Recent Developments/Updates
6.11 Equimedical
6.11.1 Equimedical Corporation Information
6.11.2 Equimedical Hemostatic Agents Description and Business Overview
6.11.3 Equimedical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Equimedical Hemostatic Agents Product Portfolio
6.11.5 Equimedical Recent Developments/Updates
6.12 Vascular Solutions
6.12.1 Vascular Solutions Corporation Information
6.12.2 Vascular Solutions Hemostatic Agents Description and Business Overview
6.12.3 Vascular Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Vascular Solutions Hemostatic Agents Product Portfolio
6.12.5 Vascular Solutions Recent Developments/Updates
6.13 Marine Polymer Technologies
6.13.1 Marine Polymer Technologies Corporation Information
6.13.2 Marine Polymer Technologies Hemostatic Agents Description and Business Overview
6.13.3 Marine Polymer Technologies Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Marine Polymer Technologies Hemostatic Agents Product Portfolio
6.13.5 Marine Polymer Technologies Recent Developments/Updates
6.14 Z-Medica
6.14.1 Z-Medica Corporation Information
6.14.2 Z-Medica Hemostatic Agents Description and Business Overview
6.14.3 Z-Medica Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Z-Medica Hemostatic Agents Product Portfolio
6.14.5 Z-Medica Recent Developments/Updates
6.15 CryoLife
6.15.1 CryoLife Corporation Information
6.15.2 CryoLife Hemostatic Agents Description and Business Overview
6.15.3 CryoLife Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.15.4 CryoLife Hemostatic Agents Product Portfolio
6.15.5 CryoLife Recent Developments/Updates
6.16 BioCer Entwicklungs
6.16.1 BioCer Entwicklungs Corporation Information
6.16.2 BioCer Entwicklungs Hemostatic Agents Description and Business Overview
6.16.3 BioCer Entwicklungs Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.16.4 BioCer Entwicklungs Hemostatic Agents Product Portfolio
6.16.5 BioCer Entwicklungs Recent Developments/Updates
6.17 Biom’Up SAS
6.17.1 Biom’Up SAS Corporation Information
6.17.2 Biom’Up SAS Hemostatic Agents Description and Business Overview
6.17.3 Biom’Up SAS Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Biom’Up SAS Hemostatic Agents Product Portfolio
6.17.5 Biom’Up SAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostatic Agents Industry Chain Analysis
7.2 Hemostatic Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostatic Agents Production Mode & Process
7.4 Hemostatic Agents Sales and Marketing
7.4.1 Hemostatic Agents Sales Channels
7.4.2 Hemostatic Agents Distributors
7.5 Hemostatic Agents Customers
8 Hemostatic Agents Market Dynamics
8.1 Hemostatic Agents Industry Trends
8.2 Hemostatic Agents Market Drivers
8.3 Hemostatic Agents Market Challenges
8.4 Hemostatic Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
